# Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors

> **NCT00516451** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 9 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** BMS-690514

## Key facts

- **NCT ID:** NCT00516451
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2008-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516451, "Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00516451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*